Poor outcome and prolonged persistence of SARS-CoV-2 RNA in COVID-19 patients with haematological malignancies; King's College Hospital experience

Br J Haematol. 2020 Sep;190(5):e279-e282. doi: 10.1111/bjh.16935. Epub 2020 Aug 10.
No abstract available

Keywords: COVID-19; SARS-CoV-2; haematological malignancies; lymphoid malignancies; myeloid malignancies; stem cell transplantation.

Publication types

  • Comparative Study
  • Letter

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Betacoronavirus / metabolism*
  • COVID-19
  • Cohort Studies
  • Coronavirus Infections* / blood
  • Coronavirus Infections* / etiology
  • Coronavirus Infections* / mortality
  • Coronavirus Infections* / therapy
  • Disease-Free Survival
  • Female
  • Hematologic Neoplasms* / blood
  • Hematologic Neoplasms* / complications
  • Hematologic Neoplasms* / mortality
  • Hematologic Neoplasms* / therapy
  • Humans
  • Male
  • Middle Aged
  • Pandemics*
  • Pneumonia, Viral* / blood
  • Pneumonia, Viral* / etiology
  • Pneumonia, Viral* / mortality
  • Pneumonia, Viral* / therapy
  • RNA, Viral / blood*
  • SARS-CoV-2
  • Survival Rate
  • Time Factors

Substances

  • RNA, Viral